The link between auditory deprivation (in this case of the form of APD) and cognition has long-term outcomes and should not be thought as a cross-sectional one [17, 18]. Thus, it is of outmost importance to longitudinally evaluate patients with ATX-FXN, document the cognitive deficits when identifying APD at an early stage, and provide appropriate management for these challenging patients. Could this improve patients’ quality of life? This remains to be confirmed. Furthermore, the issue of a possible use of these findings as a biomarker for longitudinal or therapeutic studies remains open and requires novel studies.
Friday, February 19, 2021
Friedreich’s Ataxia and Auditory Processing Disorder
Teive, H.A., Iliadou, V.M. & Manto, M.; Cerebellum (2021). doi:10.1007/s12311-021-01238-7
